Introduction: Sulphasalazine and 5-aminosalicylic acid derivatives K. D. Rainsford OriginalPaper Pages: 199 - 200
Sulphasalazine metabolites in experimental inflammation: Modulation of neutrophil function C. Von RitterM. B. GrishamD. N. Granger OriginalPaper Pages: 201 - 207
Actions of sulphasalazine and its metabolites on polymorphonuclear leucocyte superoxide I. HafströmL. Kanerud OriginalPaper Pages: 209 - 217
Actions of sulphasalazine and analogues in animal models of experimental colitis L. -G. AxelssonS. Ahlstedt OriginalPaper Pages: 219 - 232
Actions of sulphasalazine and analogues on mucosal eicosanoid formation and metabolism in patients with ulcerative colitis K. LauritsenL. S. LaursenJ. Rask-Madsen OriginalPaper Pages: 233 - 245
5-aminosalicylic acid preparations in the treatment of inflammatory bowel disease G. F. BonnerW. B. Ruderman OriginalPaper Pages: 247 - 262
A critical evaluation of the therapeutic benefits and side-effects of aminosalicylate analogues in the treatment of inflammatory bowel disease M. A. Peppercorn OriginalPaper Pages: 263 - 276
Delivery, safety and efficacy of 5-aminosalicylate preparations I. BjarnasonA. J. Macpherson OriginalPaper Pages: 277 - 287
The treatment of ulcerative colitis with balsalazide sodium J. R. B. Green OriginalPaper Pages: 289 - 295
Effects of sulphasalazine in experimental arthritis P. GilletJ. Y. JouzeauP. Netter OriginalPaper Pages: 307 - 313
Sulphasalazine and aminosalicylates in rheumatoid and related arthropathies K. D. RainsfordW. W. Buchanan OriginalPaper Pages: 323 - 330